Evidence map›Paper›PMID 34741934›Full record

ArticleJournal of chromatography. B, Analytical technologies in the biomedical and life sciences2021

Enabling online determination of the size-dependent RNA content of lipid nanoparticle-based RNA formulations.

Xiujuan Jia, Yong Liu, Angela M Wagner, Michelle Chen, Yuejie Zhao, Katelyn J Smith, Dan Some, Andreas M Abend, Justin Pennington

Open access · hybridAbstract readEvaluation Study
In one paragraph

Article in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions.Small (Weinheim an der Bergstrasse, Germany) · 2024
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Drug Product Development of Lipid Nanoparticle-Based mRNA Therapeutics and Vaccines.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Xiujuan JiaAnalytical Sciences, Analytical Research and Development, MRL, Merck & CO., Inc., Rahway, NJ, USA. Electronic address: xiujuan_jia@merck.com.
Yong LiuAnalytical Sciences, Analytical Research and Development, MRL, Merck & CO., Inc., Rahway, NJ, USA.
Angela M WagnerSterile and Specialty Products, Pharmaceutical Sciences, MRL, Merck & CO., Inc., Kenilworth, NJ, USA.
Michelle ChenWyatt Technology Corporation, Goleta, CA, USA.
Yuejie ZhaoAnalytical Sciences, Analytical Research and Development, MRL, Merck & CO., Inc., Rahway, NJ, USA.
Katelyn J SmithPreformulation, Analytical Research and Development, MRL, Merck & CO., Inc., Kenilworth, NJ, USA.
Dan SomeWyatt Technology Corporation, Goleta, CA, USA.
Andreas M AbendAnalytical Sciences, Analytical Research and Development, MRL, Merck & CO., Inc., Rahway, NJ, USA.
Justin PenningtonAnalytical Sciences, Analytical Research and Development, MRL, Merck & CO., Inc., Rahway, NJ, USA.
Merck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The potential of lipid nanoparticles (LNPs) as nucleic acid delivery vehicles has been demonstrated in recent years, culminating in the emergency use approval of LNP-based mRNA SARS-CoV-2 vaccines in late 2020. The determination of RNA content relative to LNP size can be important to the understanding of efficacy and adverse effects. This work presents the first description of a facile and rapid analytical method for online, size-dependent RNA payload distribution measurement using data from multi-angle light scattering, ultraviolet and refractive index detectors following separation of the LNPs by size-exclusion chromatography. The analysis was validated by size-based fractionation of the LNPs with subsequent offline analysis of the fractions. Four LNPs formulated with different PEG-lipids and different lipid compositions were tested. Good agreement was observed between the online and offline size-based RNA distributions among all four LNPs, demonstrating the utility of the online method for LNP-encapsulated RNA in general, and suggesting a means for simplified biophysical quantitation of a dosing-related critical quality attribute.

Indexed as

Chromatography, GelCOVID-19COVID-19 VaccinesDrug CarriersDrug Delivery SystemsHumansLipidsNanoparticlesParticle SizeRNA, MessengerRNA, ViralSARS-CoV-2COVID-19 VaccinesDrug CarriersLipidsRNA, MessengerRNA, ViralLipid nanoparticleMulti-angle light scatteringOnline analysisRNASize-dependentSize exclusion chromatography

Identifiers

PMID34741934
PMCPMC9760250
OpenAlexW3210465126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.